Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Ahn

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Chinese Clinical Oncology|February 21, 2020
Biliary tract cancer and genomic alterations in homologous recombinant deficiency: exploiting synthetic lethality with PARP inhibitorsDaniel H Ahn, Tanios Bekaii-Saab
Chinese Clinical Oncology|July 9, 2019
AJCC 8th edition staging system for pathologically versus clinically staged intrahepatic cholangiocarcinoma (iCCA): ready for prime time?Daniel H Ahn, Tanios Bekaii-Saab
Journal of Gastrointestinal Oncology|July 11, 2024
Minimal residual disease monitoring via ctDNA: a case report of Lynch syndrome with synchronous colorectal cancer and review of literatureCody Eslinger, Christina Wu, Daniel H Ahn
Journal of Oncology Practice|April 12, 2018
Genetic Diversity and Treatment Implications in Gastric and Gastroesophageal Cancers: One Size Does Not Fit AllDaniel H Ahn, Tanios S Bekaii-Saab
Gastrointestinal Cancer : Targets and Therapy|February 14, 2017
Spotlight on bevacizumab in metastatic colorectal cancer: patient selection and perspectivesManojkumar Bupathi, Daniel H Ahn, Tanios Bekaii-Saab
Hepatobiliary Surgery and Nutrition|May 16, 2017
Therapeutic options for intrahepatic cholangiocarcinomaManojkumar Bupathi, Daniel H Ahn, Tanios Bekaii-Saab
Biomedicines|March 13, 2019
Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal MalignanciesMohamad B Sonbol, Daniel H Ahn, Tanios Bekaii-Saab
Cancers|June 13, 2018
Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic AdenocarcinomaDaniel H Ahn, Ramesh K Ramanathan, Tanios Bekaii-Saab
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 5, 2020
The Role of Immune Checkpoint Inhibitors in Colorectal AdenocarcinomaDaniel R Almquist, Daniel H Ahn, Tanios S Bekaii-Saab
Korean Circulation Journal|May 11, 2019
Metastatic Neuroendocrine Tumor with Cardiac Involvement Utilizing Multi-Modality ImagingReza Arsanjani, Pradyumna Agasthi, Daniel H Ahn, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Chinese Clinical Oncology|February 21, 2020
Biliary tract cancer and genomic alterations in homologous recombinant deficiency: exploiting synthetic lethality with PARP inhibitorsDaniel H Ahn, Tanios Bekaii-Saab
Chinese Clinical Oncology|July 9, 2019
AJCC 8th edition staging system for pathologically versus clinically staged intrahepatic cholangiocarcinoma (iCCA): ready for prime time?Daniel H Ahn, Tanios Bekaii-Saab
Journal of Gastrointestinal Oncology|July 11, 2024
Minimal residual disease monitoring via ctDNA: a case report of Lynch syndrome with synchronous colorectal cancer and review of literatureCody Eslinger, Christina Wu, Daniel H Ahn
Journal of Oncology Practice|April 12, 2018
Genetic Diversity and Treatment Implications in Gastric and Gastroesophageal Cancers: One Size Does Not Fit AllDaniel H Ahn, Tanios S Bekaii-Saab
Gastrointestinal Cancer : Targets and Therapy|February 14, 2017
Spotlight on bevacizumab in metastatic colorectal cancer: patient selection and perspectivesManojkumar Bupathi, Daniel H Ahn, Tanios Bekaii-Saab
Hepatobiliary Surgery and Nutrition|May 16, 2017
Therapeutic options for intrahepatic cholangiocarcinomaManojkumar Bupathi, Daniel H Ahn, Tanios Bekaii-Saab
Biomedicines|March 13, 2019
Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal MalignanciesMohamad B Sonbol, Daniel H Ahn, Tanios Bekaii-Saab
Cancers|June 13, 2018
Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic AdenocarcinomaDaniel H Ahn, Ramesh K Ramanathan, Tanios Bekaii-Saab
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 5, 2020
The Role of Immune Checkpoint Inhibitors in Colorectal AdenocarcinomaDaniel R Almquist, Daniel H Ahn, Tanios S Bekaii-Saab
Korean Circulation Journal|May 11, 2019
Metastatic Neuroendocrine Tumor with Cardiac Involvement Utilizing Multi-Modality ImagingReza Arsanjani, Pradyumna Agasthi, Daniel H Ahn, et al.
Pageof 8